The GSK vaccine for zoster is SHINGRIX.
Shingrix: The GSK Zoster Vaccine Explained
Shingrix is a vaccine developed by GlaxoSmithKline (GSK) specifically for the prevention of herpes zoster (HZ), commonly known as shingles. Here's a more detailed look:
- Indication: Shingrix is indicated for:
- Adults aged 50 years and older.
- Adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy (as stated in the reference).
In summary, Shingrix is the GSK vaccine designed to protect against shingles in adults.
